Stockreport

Parabilis Medicines Announces Oversubscribed $305 Million Financing to Support Ongoing FOG-001 (zolucatetide) Clinical Development Across a Broad Range of Tumors and Advance Pioneering Pip...

Janus Henderson Group plc Ordinary Shares  (JHG) 
Last janus henderson group plc ordinary shares earnings: 4/30 04:00 am Check Earnings Report
US:NYSE Investor Relations: snl.com/irw/corporateprofile/4147331
PDF CAMBRIDGE, Mass., January 08, 2026 BUSINESS WIRE )--Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for pe [Read more]